Mouse strains that are homozygous for the resistant allele of Fv2 (Fv2 rr ) have few actively cycling BFU-Es. In this report, we demonstrate that the control of BFU-E cycling is encoded by a gene linked to, but distinct from, Fv2, and suggest that this gene is the dual-specific protein phosphatase Cdc25A, which regulates the G1-to S-phase transition of the cell cycle. We show that a naturally occurring allele of Cdc25A, which increases Cdc25A phosphatase activity and promotes cell-cycle progression, segregates in mouse strains that exhibit high levels of BFU-E cell cycling. In wild-type mice, this allele of Cdc25A does not overtly affect erythropoiesis; however, when this allele is combined with a mutation of the Kit receptor (Kit WV ), the anemia of the mice is enhanced. Furthermore, overexpression of Cdc25A in bone marrow cells causes a defect in the BFU-E colony formation. These results suggest that proper regulation of the cell cycle through Cdc25A is required for normal erythropoiesis. (Blood. 2002;100:3804-3811)
Introduction
Friend-virus-induced erythroleukemia progresses through 2 characteristic stages. Initially, there is a polyclonal expansion of infected cells, followed by the acquisition of further mutations and the emergence of a malignant clone. 1, 2 The specificity of Friend virus for the erythroid lineage and the characteristic progression of the Friend erythroleukemia has allowed for the identification of a number of host genes that regulate leukemogenesis after Friend virus infection. One of these host genes, the Friend virus susceptibility gene 2 (Fv2) , was first identified by Lilly 3 more than 30 years ago as a gene that controlled the expansion of infected cells during the early stage of the disease. Mice homozygous for the resistant allele of Fv2 (Fv2 rr ) are resistant to Friend disease. Even though the virus infects early erythroid progenitors (erythroid blast-forming units [BFU-Es] ) that are target cells for Friend virus, the infected cells fail to expand. 4 Two hypotheses have been put forward to explain the mechanism of Fv2 action. First, it has been proposed that Fv2 regulates complex formation between the erythropoietin receptor (EpoR) and the virally encoded glycoprotein, gp55, and thereby regulates a mitogenic signal to infected erythroid cells. 5, 6 Second, Fv2 has been proposed to regulate cell-cycle progression of BFU-E. Mice homozygous for the resistant allele of Fv2, Fv2 rr , have few BFU-Es that are actively cycling as measured by their resistance to killing by [ 3 H]thymidine and hydroxyurea. 7 In contrast, the BFU-Es from mice homozygous or heterozygous for the sensitive allele of Fv2 are actively cycling. Because retroviral infection requires that the target cell be actively cycling for productive infection, the cell-cycling differences between Fv2-sensitive and -resistant mice might explain the resistance to erythroleukemia mediated by Fv2. 1, 8 Recently, the Fv2 locus was shown to encode a naturally occurring truncated form of Mst1r (formerly the Stk receptor tyrosine kinase), known as short-form Stk or Sf-Stk. 9 The identification of the Sf-Stk receptor as Fv2 is consistent with the possibility that Fv2 functions as a component of the gp55/EpoR complex. However, the genetic linkage mapping that was used to identify Sf-Stk as Fv2 was based solely on scoring the expansion of infected cells in the spleen of infected mice and did not analyze the cell-cycle status of BFU-E. 9, 10 Although it is clear that Sf-Stk is essential for the expansion of infected cells early during Friend erythroleukemia, it is unclear whether the expression of Sf-Stk in Fv2 ss is responsible for the observed differences in cell cycling between Fv2 rr and Fv2 ss mice.
In this report we show that the control of BFU-E cell cycling is encoded by a gene linked to, but distinct from, Mst1r/Fv2. We identify a naturally occurring mutation in the cell-cycle regulatory protein phosphatase Cdc25A that segregates with the increased cell cycling of BFU-E observed in Fv2 ss mice. This point mutation in the noncatalytic amino-terminal domain of Cdc25A results in increased phosphatase activity. Furthermore, primary mouse embryo fibroblast cultures derived from mice carrying the Cdc25A mutation exhibited increased growth rates and entered S phase on average 1 to 2 hours earlier than congenic control cells, which correlated with an earlier activation of cyclin-dependent kinase 2 (CDK2) activity. Although inbred strains of mice that carry the mutant Cdc25A allele exhibited no gross defects in erythropoiesis, when this allele was combined with a mutation in the Kit receptor (Kit Wv ), the anemia of Kit Wv /Kit Wv mice was significantly enhanced. Cell-cycle control and, in particular, the role of Cdc25A in the regulation of erythropoiesis was further demonstrated by the observation that overexpression of either the wild-type or mutant allele of Cdc25A in bone marrow cells had a profound effect on the formation of BFU-E. Based on these results, we propose that an activating mutation in Cdc25A causes the alterations in BFU-E cycling observed in Fv2 ss mice and that proper cell-cycle control mediated through Cdc25A is required for normal erythropoiesis.
Materials and methods
Testing BFU-E cycling by hydroxyurea sensitivity C57BL/6J, BALB/cJ, and 129P3 (formerly 129/J) mice were purchased from JAX (Bar Harbor, ME). At 10 weeks of age, 5 mice from each strain were injected with hydroxyurea (1 mg/g body weight) in 250 L phosphate-buffered saline (PBS), and 5 control mice from each strain were injected with 250 L PBS. One hour after injection, the mice were killed and bone marrow cells were harvested. Then 1 ϫ 10 5 cells were plated in Methocult with recombinant cytokines (StemCell Technologies, Vancouver, BC, Canada) for BFU-E assays, and 1 ϫ 10 4 cells were plated for erythroid colony-forming unit (CFU-E) assays. Triplicate assays were performed for each mouse. BFU-Es were counted after 7 days, and CFU-Es were counted after 2 days. BFU-Es and CFU-Es were identified using acid benzidine staining. Percentage BFU-E or CFU-E killed by hydroxyurea was calculated as described previously. 7 
Infection of mice with Friend virus
Three 10-week-old C57BL/6J, BALB/cJ, and 129P3 mice were injected with NB tropic FV-P as previously described. 10 Fourteen days after infection, the mice were killed and their spleens were removed, weighed, and compared with the average-weight spleens of 2 uninfected controls.
Isolation of RNA and reverse transcription-polymerase chain reaction cloning and sequencing of Cdc25A alleles from C57BL/6J and BALB/cJ mice RNA was isolated from bone marrow and kidneys of C57BL/6J and BALB/cJ mice using Trizol (Gibco-BRL, Grand Island, NY) reagent. cDNA was generated from total RNA using random hexamers as primers and Superscript Reverse Transcriptase (Gibco-BRL). The coding region of Cdc25A was amplified from cDNA samples using primers corresponding 5Ј to the translation start site and 3Ј just downstream of the TGA stop codon (5Ј primer, 5Ј-GGGATCCCATGGAACTGGGCCCGAG-3Ј; 3Ј primer, 5Ј-GAAGCTCAGGCTGCTACCATT-3Ј). Multiple clones of full-length polymerase chain reaction (PCR) fragments that were derived from C57BL/6J and BALB/cJ kidney and bone marrow cDNA were sequenced.
PCR assay to detect the Cdc25A His128Gln allele
PCR primers that flanked the mutation in codon 128 were generated so that the presence of the CAC histidine codon would generate an Alw44I restriction site (5Ј primer, 5Ј-AGCCACTCTGATTCTCTAGTGCA-3Ј; 3Ј primer, 5Ј-GGTCGATGAGGTGAAAGGTGTC-3Ј; underlined nucleotides in the 5Ј primer are mismatches that generate the Alw44I site in the Cdc25A 128His allele). DNA was isolated from F2 progeny of the Fv2 mapping backcross and Fv2 congenic strains, as previously described. 10 DNA from inbred strains was purchased from the Jackson Laboratory Mouse DNA repository (Bar Harbor, ME). PCR was performed as previously described. 10 Amplification conditions for these primers were 1 minute at 94°C, 2 minutes at 62°C, and 1 minute at 72°C for 40 cycles and 7 minutes at 72°C for 1 cycle. Two microliters from a 20-L PCR reaction was cut with Alw44I in a total reaction volume of 20 L according to the manufacturer's instructions. The Alw44I digests were run on a 10% acrylamide (19:1) gel.
Expression of GST-Cdc25A 128Gln and GST-Cdc25A 128His and analysis of phosphatase activity A clone of human CDC25A fused in-frame to glutathione S-transferase (GST) was obtained from Dr Helen Piwnica-Worms (Washington University, St Louis, MO). The His128Gln mutation was introduced into this clone using the Chameleon Double-Stranded, Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. The GST-Cdc25A His128Gln , GST-Cdc25A WT , and GST proteins were produced as previously described. 11 To determine the activity of these protein phosphatases, bacterially expressed GST-CDC25A 128His , GST-CDC25A 128Gln , or GST alone were incubated in a final volume of 200 L with 40 mM para-nitrophenyl-phosphate (pNPP), 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA (ethylenediaminetetraacetic acid), and 1 mM dithiothreitol (DTT) for the indicated time at 30°C. Reactions were stopped by the addition of 1 mL of 0.2 M NaOH, and absorbance at 410 nm was measured.
Cell-cycle analysis of the mouse embryo fibroblast cultures
Mouse embryo fibroblast (MEF) cultures were derived from C57BL/6J embryos and B6.C-H7 b /By embryos harvested at day 12.5 of embryogenesis. 12 Growth curves were generated by plating 1 ϫ 10 3 cells/well in 24-well plates. Cells were trypsinized and counted using a Coulter counter at all indicated points in triplicate, and the data presented are representative of 3 independent experiments using MEF cultures derived from independent embryos. Cell-cycle progression was analyzed by starving confluent MEF cultures in low serum (0.1% fetal calf serum [FCS]) for 24 hours. Cells were then trypsinized, split 1:2, and replated in media containing 10% FCS. At the indicated times, cells were trypsinized and harvested and then resuspended in 1 mL ice-cold PBS and fixed with 70% EtOH. Fixed cells were resuspended in 100 L of 150 mM NaCl, 100 mM Tris-HCl, pH 7.6, and 900 L 0.1% Na-citrate, pH 7.6, 10 mM NaCl, was added. Cells were stained by first adding 20 L RNase A (1 mg/mL) and then adding 20 L propidium iodide (PI; 1 mg/mL). Cells were stained for 20 minutes at 25°C, and the PI staining was determined by flow cytometry. The percentage of cells in S phase was calculated using the Multicycle (Phoenix Flow Systems, San Diego, CA) program.
Determination of CDK2 histone H1 kinase activity
H1 kinase assays were performed as described. 13, 14 In brief, MEF cultures were grown to confluence in Dulbecco modified Eagle medium (DMEM) and 5% FCS. Cells were trypsinized, split 1:3, and replated in media containing 0.1% FCS for 24 hours. The low-serum media were removed, and cells were cultured for the indicated times in media containing 5% serum. For kinase assays, cells were trypsinized at the indicated times, washed once with ice-cold PBS, and resuspended in 1 mL NP40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.5% NP40, 50 mM NaF, 1 mM sodium orthovanadate, and 1ϫ protease inhibitors [Complete Protease Inhibitor Cocktail; Roche Diagnostics, Indianapolis, IN]). Lysates were sonicated (3 pulses of 5 seconds each on maximum setting) and then incubated for 30 minutes on ice. They were then centrifuged at 13 000 rpm for 15 minutes at 4°C to remove insoluble material. CDK2 was immunoprecipitated using anti-CDK2 antibody (M2) from Santa Cruz Biotechnology (Santa Cruz, CA) and Protein A Sepharose beads (Sigma-Aldrich, St Louis, MO) for 4 to 8 hours at 4°C. H1 kinase assays were performed as described. 14 Generation and analysis of Kit WV /Kit WV ;Cdc25A His128Gln mice C57BL/6J-Kit WV /ϩ mice were crossed with B6.C-H7b/By (Cdc25A His128Gln/ His128Gln ) mice. F1 mice that were Kit WV /ϩ were intercrossed. Kit WV /Kit WV F2 progeny were identified by coat color, and their survival times and hematocrit levels were measured.
Infection of bone marrow cells with Cdc25A WT and Cdc25A His128Gln retroviruses and determination of BFU-E colony-forming ability of infected cells
Human Cdc25A 128His and Cdc25A 128Gln were cloned in pMSCV-neo as BamH1-EcoR1 fragments to generate pMSCV-Cdc25A WT and pMSCVCdc25A His128Gln . Recombinant virus was generated as previously described. 15 Bone marrow was isolated from the femur of an adult BALB/cJ mouse and was resuspended in 750 L Iscove modified Dulbecco medium (IMDM) and 5% FCS. An equal volume of bone marrow cells (250 L) was incubated with each viral supernatant supplemented with 10 ng/mL stem cell factor (SCF), 10 ng/mL interleukin-3 (IL-3; both from PeproTech, Rocky Hill, NJ), and 8 g/mL polybrene (5 mL total volume; SigmaAldrich) overnight at 37°C. The next morning, 1 ϫ 10 5 infected cells were plated in Methocult media (Stem Cell Technologies) containing 3 U/mL EPO, 100 ng/mL SCF, and 1 mg/mL G418 (0.719 mg/mL active ingredient; all 3 a gift from D. Wojchowski, Pennsylvania State University) in triplicate for each virus. After 7 days, BFU-Es were stained in situ using acid benzidine stain.
Results

Control of BFU-E cell cycling is genetically distinct from Fv2-mediated control of Friend erythroleukemia
Cloning of the Fv2 locus demonstrated that Sf-Stk is required for the expansion of infected cells early during the progression of Friend erythroleukemia. 9 However, the cloning of Fv2 was based on linkage mapping that used the expansion of infected cells in the spleens of infected mice as a phenotypic readout; thus, the role of Sf-Stk in the regulation of BFU-E cell cycling has not been investigated. 9, 10 We set out to test whether Sf-Stk was involved in regulating BFU-E cell cycling by testing whether sensitivity to Friend erythroleukemia and altered BFU-E cell cycling were genetically separable.
The original analysis of the differences in BFU-E cell cycling between Fv2 rr and Fv2 ss mice was performed using congenic mice that were bred based on their sensitivity to Friend erythroleukemia. 7 Thus, if the gene controlling BFU-E cell-cycle status was closely linked to Fv2, it would have been present in the congenic region, and the cosegregation of BFU-E cell cycling with SF-Stk/ Fv2 status in these mice would not have constituted proof of genetic identity. To address this problem, we analyzed a variety of inbred mouse strains for their susceptibility to Friend erythroleukemia and for the cycling status of BFU-E. Because inbred strains were not developed based on their susceptibility to Friend virus, we reasoned that we might identify a strain where the 2 traits were separable. We used C57BL/6J mice as the Fv2 rr and BFU-E out-of-cycle control strain and BALB/cJ mice as the Fv2 ss and BFU-E actively cycling control strain. The initial strain tested was 129P3. Although 129P3 mice have been shown to be Fv2 ss , 16 we first confirmed the susceptibility of all 3 strains to Friend erythroleukemia. Ten-week-old 129P3, C57BL/6J, and BALB/cJ mice were infected with the NB-tropic polycythemia-inducing strain of Friend virus. Fourteen days later the mice were assayed for susceptibility by comparing the spleen weights of infected mice with those of uninfected controls ( Table 1) . As expected, C57BL/6J mice were resistant to Friend virus, as exhibited by the limited 1.4-fold increase in spleen size. In contrast, BALB/cJ mice were completely sensitive to Friend virus (20.2-fold increase in spleen size). We also observed sensitivity in the 129P3 mice; however, the expansion of cells in the spleen was not as extensive as that seen in BALB/cJ mice (4.0-fold increase in 129P3 compared with 20.2-fold in the BALB/cJ). Although the increase in spleen size was significantly less than that observed in the BALB/cJ mice, spleens from 129P3 mice were clearly infected as evidenced by macroscopic spleen foci present on some spleens (data not shown).
The percentage of actively cycling BFU-E was measured in the 3 strains by determining the sensitivity of BFU-E to killing by hydroxyurea ( Table 1) . As expected, BFU-Es from C57BL/6J mice were resistant to killing by hydroxyurea, whereas BALB/cJ BFU-Es were sensitive to hydroxyurea (16.2% killed in C57BL/6J vs 66.5% killed in BALB/cJ). In contrast, 129P3 mice sensitive to Friend erythroleukemia were resistant to hydroxyurea (12.4% of BFU-E killed by hydroxyurea). These results clearly demonstrate that susceptibility to Friend erythroleukemia and control BFU-E cell cycling are genetically separable.
Point mutation in Cdc25A segregates with Fv2 ss mouse strains that exhibit altered cell cycling of BFU-E
We reasoned that the gene that controls BFU-E cycling must be closely linked to Fv2 because Fv2 ss congenic strains exhibit increased BFU-E cycling. 7 Thus, genes that mapped near the Fv2 locus on mouse chromosome 9 or the homologous region on human chromosome 3 would be candidates for the gene that regulates BFU-E cycling. One ideal candidate gene that mapped to this region in human and mouse is Cdc25A. 17, 18 Cdc25A is a member of the Cdc25 family of dual-specific protein phosphatases that regulate cell-cycle transitions by dephosphorylating and activating CDKs. 19 Cdc25A functions during the G1-to S-phase transition of the cell cycle. The primary targets for Cdc25A are the CDK2-cyclin E and CDK2-cyclin A complexes, which act to drive the cell from G1 to S phase. 19 If Cdc25A is the Fv2-linked gene that regulates BFU-E cell cycling, then different alleles of Cdc25A should be present in strains that differ in BFU-E cell-cycle status. To determine whether differences in the coding sequence of Cdc25A were responsible for altered BFU-E cycling, we made full-length Cdc25A cDNA clones from RNA isolated from either C57BL/6J (BFU-E out-of-cycle) or BALB/cJ (BFU-E in-cycle) mice. Sequencing of the clones revealed that the coding sequence of the BALB/cJ Cdc25A gene contained a C to A change in codon 128 that converts a CAC histidine codon (Cdc25A 128His ) to a CAA glutamine codon (Cdc25A 128Gln ). This mutation lies in the amino-terminal noncatalytic domain of Cdc25A near the end of a block of 24 amino acids that are absolutely conserved in mouse, human, and rat. Comparison of the sequence of this region in human and rat with sequence from BALB/cJ and C57BL/6J revealed that the C57BL/6J allele, Cdc25A 128His , is conserved in human and rat, suggesting that this allele may be the "wild-type" allele ( Figure 1) . 20, 21 Using this mutation, we developed a PCR-based assay to distinguish between the 2 alleles. We mapped Cdc25A relative to For all strains, more than 75% of CFU-Es were killed by hydroxyurea treatment. Ten mice of each strain (5 injected with hydroxyurea, 5 uninjected controls) were used to calculate the percentage of BFU-Es killed by hydroxyurea. 7 As a control, the percentage of CFU-Es killed by hydroxyurea was also measured. Friend virus sensitivity was measured by examining spleen weight 2 weeks after infection with Friend virus.
Fv2 using a (C3HeB/FeJ ϫ C57BL/6J)F1 ϫ C57BL/6J backcross panel. 10 Cdc25A mapped approximately 2 cM distal to Fv2 (Figure  2A) . At the same time, we scored the presence of this mutation in a panel of DNA samples representing 22 inbred or congenic mouse strains tested for susceptibility to Friend erythroleukemia, including 10 strains that exhibited differences in BFU-E cell-cycle status as measured by sensitivity to hydroxyurea or [ 3 H]thymidine. 7 The 6 strains in which BFU-E were out of cycle all contained the Cdc25A 128His allele, whereas the 5 strains in which most BFU-Es were in cycle all contained the Cdc25A 128Gln allele ( Figure 2B) . Thus, the Cdc25A mutation segregated perfectly with differences in BFU-E cell-cycle status, raising the possibility that the Cdc25A 128Gln mutation is responsible for the differences in BFU-E cycling rather than Fv2 itself.
Cdc25A His128Gln mutation results in increased phosphatase activity
Cdc25A is a positive regulator of the cell cycle. Overexpression of Cdc25A can lead to cell proliferation and transformation. 22, 23 Thus, mutations that increase Cdc25A activity might lead to increased cell proliferation. Cdc25A and the other family members, Cdc25B and C, are modular proteins. The carboxy-terminal portion of the protein contains the phosphatase domain, and the amino-terminal domain is thought to regulate the activity of the enzyme. Truncation of the amino-terminal domain results in a 3-to 10-fold increase in phosphatase activity, suggesting that this domain may directly inhibit phosphatase activity. 24, 25 We sought to determine whether the His128Gln mutation, which lies in the amino-terminal regulatory domain, affected the phosphatase activity of Cdc25A. The complete coding domain of human CDC25A 128His and CDC25A 128Gln were fused in-frame with GST, and the fusion proteins were produced in Escherichia coli. Phosphatase activity of purified fusion proteins was determined by measuring the conversion of para-nitrophenyl phosphate to para-nitrophenol using absorbance at 410 nm. In 3 separate experiments, CDC25A 128Gln consistently demonstrated an increase in phosphatase activity (Figure 3 ). These results suggest that a point mutation in the amino-terminal domain of Cdc25A may alter the conformation of the protein, resulting in increased phosphatase activity.
Cells expressing Cdc25A His128Gln exhibit an accelerated cell cycle
The expression of Cdc25A is not limited to erythroid progenitors and is thought to be expressed by all dividing cells. Thus, a mutation that increases Cdc25A phosphatase activity might affect the cell-cycle parameters of many cell types. To determine whether differences in Cdc25A alleles affected cell-cycle parameters in a cell population more amenable to experimental analysis than BFU-E, we derived primary MEF cultures from C57BL/6J and the congenic B6.C-H7 b /By, which is congenic for the H7 histocompatability locus that is linked to Fv2 and Cdc25A. B6.C-H7 b /By mice carry the Cdc25A 128Gln allele, whereas the C57BL/6J MEFs express the Cdc25A 128His allele. Early-passage MEFs of each genotype were plated out, and the cultures were allowed to expand over a 6-day period. The B6.C-H7 b /By (Cdc25A 128Gln ) MEFs consistently expanded at a faster rate than the C57BL/6J(Cdc25A 128His ) MEFs ( Figure 4A ). These data support the idea that the increased phosphatase activity of Cdc25A 128Gln is associated with an increase in cell cycling. 20 and rat Cdc25A. 21 The position of codon 128 is highlighted within this domain. Below, a portion of the sequence of CDC25B2 is aligned with Cdc25A to demonstrate that the region containing the codon 128 is deleted in CDC25B2. 41 Figure 2. Linkage mapping of Cdc25A on mouse chromosome 9 and comparison of the segregation of BFU-E cell-cycle status and the 2 alleles of Cdc25A in inbred and congenic mouse strains. (A) Genetic linkage map of the region of mouse chromosome 9 containing Fv2/Stk and Cdc25A. Map distances between adjacent loci are given in cM at the left. The centromere is at the top. The linkage map was generated using a C3HheB/FeJ ϫ C57BL/6J)F1 ϫ C57BL/6J backcross panel of 425 animals. 10 The linkage map was constructed using MAPMAKER/EXP 3.0. 57 (B) Segregation of BFU-E cell-cycle status and the Cdc25A 128His and Cdc25A 128Gln alleles in inbred and congenic strains. Inbred and congenic strains were scored for the Cdc25A alleles by PCR. Results are presented in the left-side boxes. BFU-E cycling status of these strains has been determined by resistance to Cdc25A functions during the G1-to S-phase transition of the cell cycle, acting as a positive regulator of this process. 19 Thus, Cdc25A alleles with increased phosphatase activity might be expected to shorten the G1 phase and to hasten the entry into S phase of the cell cycle. To test this hypothesis, we used the MEF cultures derived from congenic mouse strains. The cultures were synchronized in G0/G1 using low-serum culture conditions and were transferred to serum-containing medium. The progression of cells into S phase was measured by staining of the cells with PI, followed by flow cytometry to determine DNA content. Between 18 and 24 hours after replating in serum-containing media, the proportion of Cdc25A 128Gln cells in S phase was significantly higher than the corresponding fraction from cells carrying the Cdc25A 128His allele ( Figure 4B ). Cdc25A positively regulates the G1-to S-phase transition by dephosphorylating CDK2-cyclin A/E complexes, which leads to an activation of CDK2 activity. Given that MEFs expressing Cdc25A 128Gln enter S phase more rapidly than those expressing Cdc25A 128His , we tested whether the decrease in G1-to S-phase transition time correlated with an earlier activation of CDK2 in Cdc25A 128Gln cells. MEF cells were synchronized in G0/G1 by culturing in low serum and then were switched to serum-containing medium to induce cell-cycle progression. CDK2 was immunoprecipitated, and histone H1 kinase activity was measured. At 12 and 14 hours following the switch to serum-containing media, Cdc25A 128Gln cells exhibited increased CDK2 activity when compared with Cdc25A 128His cells ( Figure  4C ). Taken together, these data suggest that the increase in phosphatase activity of the Cdc25A 128Gln allele results in a decreased overall cell-cycle time and an increased proliferation rate, correlating with a more rapid activation of CDK2 activity.
Cdc25A His128Gln enhances the anemia of W V /W V mice
The original observations that demonstrated differences in BFU-E cycling suggest that Cdc25A His128Gln might have an effect on erythropoiesis. 7 However, no significant differences in the number of BFU-Es or any other blood parameters have been observed between C57BL/6J mice and BALB/cJ mice. Thus, any effects of the increased BFU-E cycling must be compensated for by other mechanisms. As with other leaky mutant alleles, the effects of Cdc25A His128Gln on erythropoiesis may not be apparent except under sensitized conditions. To explore this possibility, we crossed B6.C-H7b/By (Cdc25A His128Gln ) mice with C57BL/6J mice carrying a mutation in the Kit receptor tyrosine kinase (Kit Wv (Table 2) . Thus, in mice with severe anemia, the increase in Cdc25A activity was associated with enhanced defects in erythropoiesis.
Overexpression of Cdc25A 128His or Cdc25A 128Gln inhibits BFU-E colony formation
The enhanced anemia observed in Kit Wv /Kit Wv mice that were also homozygous for the Cdc25A 128Gln allele suggested that, under sensitized conditions, alterations in cell-cycle regulation lead to defects in erythropoiesis. Work in Schizosaccharomyces pombe demonstrated that the overexpression of Cdc25 accelerates the cell cycle and induces cells to enter the S phase prematurely, which is similar to what happens to the phenotype exhibited by the Cdc25A 128Gln MEFs. 34 We next tested whether alteration of the cell cycle by overexpression of Cdc25A 128His or Cdc25A 128Gln could affect the ability of bone marrow cells to form BFU-E colonies. Cdc25A 128His and Cdc25A 128Gln were cloned to the pMSCV-neo retroviral vector, and these constructs were used to generate a virus that was used to infect bone marrow cells. Infected cells were mice were generated as described. Hematocrit levels were measured at 3 weeks of age. The Cdc25A 128Gln allele had no effect on the mild anemia of Kit Wv heterozygotes. Cells were grown to confluence and starved at low serum for 24 hours to synchronize the cells in G0/G1. Cells were then split into new media containing serum and grown for the indicated times. Cells were harvested, fixed, and stained with PI. Stained cells were analyzed by flow cytometry, and the percentage of cells in S phase was calculated by using the Multicycle (Phoenix Flow Systems) program. The graph is representative of 3 independent experiments using 3 independently derived MEF cultures for each allele. (C) Analysis of CDK2 H1 kinase activity in MEF cultures. Cells were grown in low-serum media to synchronize cells in G0/G1. Cells were then transferred to new media containing serum and grown for the indicated times. The cells were lysed, and CDK2 was immunoprecipitated. Histone H1 kinase activity was measured. 13, 14 The gel is representative of 2 independent experiments using 2 different independently derived MEF cultures for each allele. plated in methylcellulose media containing EPO, SCF, and G418, which allowed for the selection of infected cells. Overall, BFU-E colonies were more sensitive than other myeloid colonies (culture colony-forming units [CFU-Cs]). Infection with Cdc25A 128His virus resulted in a significant reduction in BFU-E (50% of control, P Ͻ .01), whereas the total number of CFU-Cs was not significantly different ( Figure 5 ). In contrast, infection with Cdc25A 128Gln resulted in an almost total loss of BFU-E and CFU-C ( Figure 5 ). This loss of colony-forming ability was not caused by low Cdc25A 128Gln viral titer. Control experiments using MEF cells that measured neo R colony formation showed that the titers of the MSCV-neo control, MSCV-Cdc25A 128His , and MSCV-Cdc25A 128Gln viruses were approximately equal (data not shown). These results suggest that BFU-Es are more sensitive to alterations in cell-cycle progression than other myeloid colony-forming cells and that the overexpression of Cdc25A 128Gln , a mild activating allele of Cdc25A, results in inhibition of erythroid and myeloid differentiation.
Discussion
Previous work on the Fv2 locus suggested 2 potential mechanisms for the resistance to Friend erythroleukemia in Fv2 rr mice. One model postulated that Fv2 was a component of the EpoR signaling complex that interferes with the interaction of virally encoded gp55 with the EpoR in Fv2 rr mice or that promotes the interaction in Fv2 ss mice. 5, 9 The second model suggested that Fv2 regulates cell cycling of BFU-E, the target cell for Friend virus, such that in Fv2 rr mice too few target cells actively cycle for productive infection. 1, 7 Although the cloning of Fv2 demonstrated that it encoded Sf-Stk, a truncated form of the Mst1r receptor tyrosine kinase, 9 which supports the first model, this finding does not rule out a role for Sf-Stk in the regulation of BFU-E cell-cycle status. In this report, we have demonstrated that altered cell cycling and susceptibility to erythroleukemia are governed by distinct genes. Furthermore, we have identified a mutation in a gene closely linked to Fv2/Sf-Stk, Cdc25A, which segregates in mouse strains that exhibit altered BFU-E cycling.
Cdc25A is a positive regulator of cell-cycle progression and plays a key role in the transition to the S phase. 19 The activity of Cdc25A is tightly regulated at several levels. Expression of the Cdc25A gene is inhibited by the Rb/E2F complexes and is induced by both c-Myc and E2F. [28] [29] [30] [31] [32] [33] Alterations in Cdc25 expression can have profound consequences on the cell cycle. Overexpression of Cdc25 in S pombe induces cells to divide at a faster rate, resulting in a small cell or "wee" phenotype. 34 In mammalian cells, overexpression of Cdc25A results in an accelerated G1-to S-phase transition. 22, 35 Both observations are consistent with our findings that the increased phosphatase activity of the Cdc25A His128Gln allele causes a shortened G1 phase and a faster expansion of cells in culture.
How might the His128Gln mutation affect the enzymatic activity of Cdc25A? In general, the enzymatic activity of the Cdc25 family appears to be regulated through its amino-terminal regulatory domain. This domain contains several phosphorylation sites for different kinases. 19, 36 Phosphorylation of these sites can positively and negatively regulate Cdc25. Phosphorylation of Cdc25A by cyclin E/CDK2 activates phosphatase activity and represents a positive feedback loop for activation of the enzyme. 37 In contrast, the amino-terminus of Cdc25A is phosphorylated by either Chk1 or Chk2 kinase in response to DNA damage, which leads to ubiquitination and degradation by the proteosome. 38, 39 Phosphorylation by Chk2 occurs at Ser123, which is located in the conserved block of 24 amino acids that contains codon 128. 40 Thus, the His128Gln mutation might alter the conformation of the protein and thereby affect the phosphorylation of this site, which in turn could affect the stability and the activity of Cdc25A. In the human homologue of CDC25B, a naturally occurring splice variant, CDC25B2, deletes this conserved region (Figure 1 ). This variant has increased phosphatase activity when used to rescue the temperature-sensitive allele of S pombe Cdc25. 41 These results, coupled with our observations presented here, suggest that this region of the amino-terminal domain plays a key role in regulating Cdc25A activity in vivo.
The His128Gln mutation in the germline of certain mouse strains causes only a modest increase in phosphatase activity. This small increase in phosphatase activity may be constrained by the fact that normal mouse development must still occur in animals expressing Cdc25A His128Gln . As discussed above, the overexpression of Cdc25 in S pombe induces premature entry into the cell cycle. 34 In a single-cell organism such as S pombe, this disregard for maintaining cell size requirements can lead to an increase in aberrant mitoses. 34 In the context of a multicellular organism, high levels of Cdc25A phosphatase activity are incompatible with normal growth and development, as demonstrated by the loss of BFU-E and CFU-C when bone marrow cells are infected with a Cdc25A 128Gln virus. Thus, the Cdc25A 128Gln allele exhibits only a modest increase in phosphatase activity and, with endogenous expression levels, is compatible with normal development. However, when placed in a sensitized background such as in the Kit Wv /Kit Wv anemic background or when overexpressed in bone marrow cells, this allele causes a significant defect in the development of erythroid and myeloid progenitors.
Analysis of tumorigenesis in humans and mice has suggested that Cdc25A and other Cdc25 family members play a role in unregulated cell growth. Overexpression of CDC25A has been observed in several human tumors and is often associated with more aggressive tumors. [42] [43] [44] [45] [46] Furthermore, overexpression of Cdc25A or Cdc25B has been shown to increase susceptibility to tumors in animal models and can transform cells in culture. 23, 47, 48 The central role of Cdc25A in promoting the G1-to S-phase transition is underscored by the observation that Cdc25A is an essential target of the G1-to S-and the intra-S-phase checkpoints. 49, 50 In response to DNA damage, CDC25A is rapidly degraded, and S-phase progression is blocked. 39 This response is regulated by the Ataxia telangiectasia-mutated (ATM)/ATMrelated (ATR) kinases that signal through a Chk1/2 kinase intermediate. 50 Chk1/Chk2 phosphorylates Cdc25A, targeting it for degradation. Using Xenopus extracts to reconstitute this checkpoint in vitro, it was shown that the addition of exogenous Cdc25A can override the checkpoint and drive the extract into S phase. 51 These results suggest that increased levels of Cdc25A or potentially increased activity of Cdc25A could drive cells through cell-cycle checkpoints, resulting in further mutations. This prediction is borne out in some tumors in humans, when the overexpression of Cdc25A is associated with more aggressive tumors. 42, 52, 53 We have not analyzed whether the progression to leukemia in mice expressing Cdc25A His128Gln is more rapid than in mice expressing the wild-type version. However, the expansion of infected cells in the spleen during the first 4 days after Friend virus infection occurs 2.7-fold faster in BALB/cJ (Cdc25A 128Gln ) mice than in 129P3 (Cdc25A 128His ) mice (R.F.P., unpublished observations, June 1996). Taken together, the observations in human tumors, the role of CDC25A in checkpoint control, and our observations that Cdc25A 128Gln -infected cells expand more rapidly, one might predict that Cdc25A His128Gln would decrease the time necessary to develop leukemia after Friend virus infection.
In wild-type mice, differences in BFU-E cell-cycling status appear to cause no overt erythropoietic phenotypes. 7 It appears that the erythropoietic compartment is sufficiently plastic to compensate for any deficiencies caused by the alteration in cell cycling. However, as is the case with other weak mutant alleles, the phenotypic effects of the Cdc25A 128Gln mutation become manifest only when placed on a sensitized background of mutations, as in Kit Wv /Kit Wv . How might alterations in cell cycling affect erythropoiesis in these mice? The Kit receptor signaling pathway plays a key role in the proliferation and survival of erythroid progenitors. 26 The Kit Wv allele results in a decrease in kinase activity (approximately 15% of wild-type) and is functionally analogous to cells being starved of SCF. 54 If Cdc25A His128Gln drives cells into the cell cycle prematurely, erythroid progenitors may die because they lack sufficient Kit/SCF signal to keep them alive. This explanation seems less likely because the overexpression of Cdc25A 128His in bone marrow cells resulted in a similar decrease (50%) in BFU-E colonies regardless of whether a high concentration of SCF (100 ng/mL; Figure 5 ) or a low concentration of SCF (10 ng/mL; R.F.P., unpublished observations, January 2002) was used. Thus, in these experiments, low levels of Kit receptor signaling did not result in cells more sensitive to alterations in the cell cycle. Alternatively, erythroid differentiation requires progenitor cells to exit the cell cycle and terminally differentiate. 55, 56 Cdc25A His128Gln in the Kit Wv cross or overexpression of either Cdc25A allele in bone marrow cells could interfere with the cell-cycle exit and disrupt normal differentiation.
In summary, we have described a naturally occurring mutation in Cdc25A that segregates with altered BFU-E cell-cycle status. These results demonstrate that the differences in BFU-E cell cycling previously ascribed to Fv2 are likely caused by this allele of Cdc25A. This mutation, in the amino-terminal regulatory domain of Cdc25A, has a moderate but discernible effect on Cdc25A phosphatase activity and a significant effect on cell-cycle status. Although this mutation has no discernible phenotypic consequences under normal conditions, the effects are manifest when the mutation is placed on the sensitized Kit Wv /Kit Wv mutant background or when either Cdc25A 128His or Cdc25A 128Gln are overexpressed in bone marrow cells. These results suggest that proper cell-cycle control is required for normal erythropoietic differentiation.
